BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will be on a panel at the UNC Alternative Investments Conference in Chapel Hill, NC.
News | 02. 16. 2011
